Article metrics

Download PDFPDF
Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot study

 

Online download statistics by month:

Online download statistics by month: May 2021 to April 2022

AbstractFullPdf
May 2021642
Jun 202114136
Jul 20211063
Aug 2021542
Sep 2021433
Oct 20218212
Nov 202111510
Dec 202116210
Jan 202210453
Feb 202211421
Mar 202210441
Apr 202213300
Total8534423